Search

Our First Drug to Market 2Q2020

We are now at a point in time where our goals are becoming a reality. With three drugs on the horizon to enter the US market within the next year, we are more than confident that Dawah Pharmaceuticals will become a known competitor in the Sterile Injectable market. We confidently predict that our initial 6 drug portfolio will generate over $1 billion in the next 10 years.


You will find a link to our investor's update video and our latest Investor Report deck. We urge you to review both materials and we are looking for serious investors who are passionate about this industry to be part of the Dawah Pharmaceuticals team.


Contact info@dawahpharma.com or dial 347-669-1693 for more information.



54 views0 comments

Recent Posts

See All

To our investors: The current international social and financial impact of COVID-19 has not affected the progress of Dawah Pharma's entry to market. If anything, it has expedited the FDA approval proc

New York, NY – The global pharmaceutical market is estimated to be valued at $1.5 trillion by 2020 and witnessing a growth of 4-5%. In the last 3 decades, the pharmaceutical market witnessed a shift f

Our contracted CMO has successfully completed the scale-up batch on the product. The three exhibit batches are scheduled for the next 3 weeks. This means that we are on target to file our ANDA with th